HomeMREO • NASDAQ
add
Mereo BioPharma Group plc - ADR
Previous close
$2.18
Day range
$2.12 - $2.27
Year range
$1.58 - $5.02
Market cap
356.16M USD
Avg Volume
1.64M
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.02M | 16.92% |
Net income | -12.89M | -43.97% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | -10.87M | -17.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.48M | 28.41% |
Total assets | 68.32M | 22.14% |
Total liabilities | 8.24M | -37.09% |
Total equity | 60.08M | — |
Shares outstanding | 159.00M | — |
Price to book | 5.74 | — |
Return on assets | -38.07% | — |
Return on capital | -42.96% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -12.89M | -43.97% |
Cash from operations | -8.33M | -4.23% |
Cash from investing | -320.00K | 54.29% |
Cash from financing | 422.00K | — |
Net change in cash | -7.32M | 16.46% |
Free cash flow | -7.36M | — |
About
Founded
2015
Website
Employees
36
